5:35 PM
 | 
Oct 30, 2012
 |  BC Extra  |  Company News

Aveo to reduce headcount

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) said it will reduce headcount by about 45 (17%) to about 235 and will reduce spending on undisclosed early stage research programs ahead of the potential U.S. launch of tivozanib for renal...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >